.
Shares in Phylogica Limited (ASX:PYC) surged almost 85 per cent yesterday after reporting a cancer pilot study success.The drug discovery group says its peptide fusions have been shown to kill aggressive, drug-resistant breast cancer cells.The company also advises its phylomer peptide fusions have been shown to significantly boost the potency of cancer drugs.Phylogica says it was not expecting such a striking result from the pilot study and has described the findings as a potential paradigm shift for cancer therapeutics.Phylogica reported a net loss of $135,000 in the first half of the 2015 financial year.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.055(4.15%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.32 | $1.24 | $3.881M | 3.078M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4847 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 8003 | 9 |
View Market Depth
| Last trade - 15.36pm 11/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |